Telehealth.
Telehealth and DTC health platforms run a different funnel — consultation-led, prescription-pathway gated, with platform health-ad policy tightening quarter-on-quarter. US-imported creative libraries don't survive an AU read. The work is rebuilding the funnel from the prescriber's point of view, where the offer holds across audits, code revisions and platform reviews.
What we design around.
- 01
Funnels lead with consultation, never substance
Top-of-funnel cannot name, depict, or imply the prescription medicine. We rebuild creative from the prescriber's point of view, not the consumer's.
- 02
OAIC consent shapes the intake form
Consent for clinical data collection, sharing, and storage runs from the very first form field. Privacy review is concurrent with form design.
- 03
Outcomes are structural, not clinical
Reported outcomes are scheduled consultations, prescriber capacity, and conversion shape — never clinical effect.
Inside this vertical.
- Compliance-aware creative · Landing pages · Paid media
ASX-Adjacent Men’s Telehealth
−42%CAC across compliant prescription flow.
- Compliance-aware creative · Landing pages
ASX-Listed Digital Health Platform
+22%New compliant funnel outperformed the legacy non-compliant one.
- Brand kit · Website design & build · Hosting & maintenance
Women’s Health DTC Platform
4 weeksBrand and site shipped compliance-first.
- Paid media · Compliance-aware creative
Men’s Health DTC Platform
−34%CAC across a re-briefed prescription flow.
- Content production · SEO
Chronic-Care Telehealth Platform
+74%Organic traffic from condition-side search intent.
- Analytics & measurement
Mental-Health Telehealth Platform
+18%Server-side tracking recovered conversions lost to consent-strip.
Want the full grid? See all selected work →
What founders ask first.
- 01
Can we mention the medicine in long-form content?
Only inside a clinician-content context, behind a consultation gate. Plain DTC content cannot. We wire the gating into the IA.
- 02
How do you handle pricing transparency?
Consult fee transparency is allowed and often advisable; medicine pricing exposed to consumer view triggers s.42DLB. The line runs through the design.
- 03
Do you support cross-border platforms?
Australian platforms with international parents are common — we work to AU rules end-to-end and don't import US patterns that breach them.
Question we didn’t cover? Brief us →